Patent Settlements: 2nd Circuit Okays Bayer's Cipro Deal But Doesn't Want To

While the U.S. Court of Appeals for the Second Circuit found that a reverse settlement agreement involving Bayer's antibiotic Cipro did not violate antitrust laws, it invited the plaintiffs to seek a reexamination of the case by the full court

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet